Community Health Systems revenue was $12.37 b in FY, 2021 which is a 4.9% year over year increase from the previous period.
Community Health Systems revenue breakdown by business segment: 21.4% from Medicare, 13.5% from Medicaid, 64.2% from Managed Care and other third-party payors and 0.9% from Other
USD | FY, 2019 | FY, 2020 | FY, 2021 |
---|---|---|---|
Revenue | 13.2b | 11.8b | 12.4b |
Revenue growth, % | (7%) | (11%) | 5% |
Cost of goods sold | 8.1b | 7.4b | 7.3b |
Gross profit | 5.1b | 4.4b | 5.1b |
Gross profit Margin, % | 39% | 37% | 41% |
Operating expense total | 4.5b | 3.3b | 3.7b |
Depreciation and amortization | 608.0m | 558.0m | 540.0m |
EBIT | 650.0m | 1.1b | 1.4b |
EBIT margin, % | 5% | 10% | 11% |
Interest expense | 1.0b | 1.0b | 885.0m |
Interest income | 3.0m | ||
Pre tax profit | (430.0m) | 422.0m | 499.0m |
Income tax expense | 160.0m | (185.0m) | 131.0m |
Net Income | (590.0m) | 607.0m | 368.0m |
EPS | (5.9) | 4.4 | 1.8 |
USD | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 |
---|---|---|---|---|---|---|---|
Revenue | 3.0b | 2.5b | 3.1b | 3.0b | 3.0b | 3.1b | 3.1b |
Cost of goods sold | 1.9b | 1.7b | 1.9b | 1.8b | 1.8b | 1.9b | 1.8b |
Gross profit | 1.1b | 819.0m | 1.2b | 1.2b | 1.2b | 1.3b | 1.3b |
Gross profit Margin, % | 37% | 33% | 40% | 84% | 41% | 40% | |
Operating expense total | 1.0b | 523.0m | 953.0m | 893.0m | 927.0m | 910.0m | 1.0b |
Depreciation and amortization | 144.0m | 141.0m | 139.0m | 138.0m | 133.0m | 137.0m | 128.0m |
EBIT | 110.0m | 296.0m | 285.0m | 326.0m | 314.0m | 340.0m | 270.0m |
EBIT margin, % | 4% | 12% | 9% | 11% | 10% | 11% | |
Interest expense | 262.0m | 260.0m | 257.0m | 231.0m | 219.0m | 216.0m | 217.0m |
Investment income | 1.0m | ||||||
Pre tax profit | (149.0m) | 35.0m | 148.0m | 34.0m | 91.0m | 154.0m | 53.0m |
Income tax expense | (183.0m) | (58.0m) | 20.0m | 69.0m | 54.0m | 10.0m | 23.0m |
Net Income | 34.0m | 93.0m | 128.0m | (35.0m) | 37.0m | 144.0m | 30.0m |
EPS | 0.2 | 0.6 | 1.0 | (0.5) | 0.0 | 0.9 | 0.0 |
USD | FY, 2019 | FY, 2020 | FY, 2021 |
---|---|---|---|
Cash | 216.0m | 1.7b | 507.0m |
Accounts Receivable | 2.3b | 1.9b | 2.1b |
Prepaid Expenses | 193.0m | 184.0m | 192.0m |
Current Assets | 3.4b | 4.5b | 3.5b |
PP&E | 5.6b | 5.3b | 5.6b |
Goodwill | 4.3b | 4.2b | 4.2b |
Total Assets | 15.6b | 16.0b | 15.2b |
Accounts Payable | 811.0m | 783.0m | 830.0m |
Short-term debt | 156.0m | 265.0m | 178.0m |
Current Liabilities | 2.3b | 2.8b | 2.4b |
Long-term debt | 13.9b | 12.6b | 12.6b |
Total Debt | 14.0b | 12.9b | 12.8b |
Total Liabilities | 17.2b | 17.1b | 16.0b |
Common Stock | 1.0m | 1.0m | 1.0m |
Additional Paid-in Capital | 2.0b | 2.1b | 2.1b |
Retained Earnings | (4.2b) | (3.7b) | (3.5b) |
Total Equity | (1.6b) | (1.1b) | (810.0m) |
Debt to Equity Ratio | -6.6 x | -8.4 x | -15.8 x |
Debt to Assets Ratio | 0.9 x | 0.8 x | 0.8 x |
Financial Leverage | -7.3 x | -10.4 x | -18.8 x |
USD | FY, 2019 | FY, 2020 | FY, 2021 |
---|---|---|---|
Net Income | (590.0m) | 607.0m | 368.0m |
Depreciation and Amortization | 608.0m | 558.0m | 540.0m |
Accounts Receivable | 93.0m | 309.0m | (136.0m) |
Accounts Payable | (157.0m) | (67.0m) | 16.0m |
Cash From Operating Activities | 385.0m | 2.2b | (131.0m) |
Purchases of PP&E | (438.0m) | (440.0m) | (469.0m) |
Cash From Investing Activities | (2.0m) | 177.0m | (524.0m) |
Long-term Borrowings | (3.6b) | (5.5b) | (4.4b) |
Dividends Paid | (99.0m) | (116.0m) | (121.0m) |
Cash From Financing Activities | (363.0m) | (895.0m) | (514.0m) |
Net Change in Cash | 20.0m | 1.5b | (1.2b) |
Interest Paid | 1.0b | 1.0b | 778.0m |
Income Taxes Paid | 3.0m | 2.0m | 4.0m |
USD | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 |
---|---|---|---|---|---|---|---|
Net Income | 34.0m | 126.0m | 254.0m | (35.0m) | 2.0m | 146.0m | 30.0m |
Depreciation and Amortization | 144.0m | 285.0m | 424.0m | 138.0m | 272.0m | 408.0m | 128.0m |
Accounts Receivable | 158.0m | 313.0m | 281.0m | (34.0m) | (32.0m) | (99.0m) | (17.0m) |
Accounts Payable | (78.0m) | (160.0m) | (81.0m) | (23.0m) | (2.0m) | 85.0m | (23.0m) |
Cash From Operating Activities | 57.0m | 1.7b | 2.1b | 101.0m | 280.0m | 400.0m | 101.0m |
Purchases of PP&E | (99.0m) | (192.0m) | (317.0m) | (105.0m) | (212.0m) | (334.0m) | (97.0m) |
Cash From Investing Activities | (109.0m) | (53.0m) | 9.0m | (120.0m) | (255.0m) | (313.0m) | (121.0m) |
Long-term Borrowings | (1.9b) | (2.3b) | (2.4b) | (3.0b) | (4.4b) | (4.4b) | (1.5b) |
Dividends Paid | (30.0m) | (57.0m) | (84.0m) | (21.0m) | (66.0m) | (95.0m) | (29.0m) |
Cash From Financing Activities | 82.0m | (321.0m) | (504.0m) | (406.0m) | (451.0m) | (469.0m) | (27.0m) |
Net Change in Cash | 30.0m | 1.3b | 1.6b | (425.0m) | (426.0m) | (382.0m) | (47.0m) |
Interest Paid | 264.0m | 486.0m | 765.0m | 203.0m | 304.0m | 572.0m | 242.0m |
Income Taxes Paid | 2.0m | 2.0m | 2.0m | 1.0m | 3.0m | 2.0m |
USD | FY, 2019 |
---|---|
EV/EBIT | 21.8 x |
EV/CFO | 36.8 x |
Revenue/Employee | 209.7k |
Debt/Equity | -6.6 x |
Debt/Assets | 0.9 x |
Financial Leverage | -7.3 x |
P/E Ratio | (0.5) |
FY, 2019 | FY, 2020 | FY, 2021 | |
---|---|---|---|
Adjusted Admissions | 1.21 m | 973.57 k | 950.72 k |
Average Length of Stay (Days) | 4.4 | 4.7 | 5 |
Beds in Service | 14.44 k | 12.42 k | 11.63 k |
General Acute Care Hospitals | 100 | 87 | 81 |
Hospital Admissions | 557.96 k | 470.33 k | 442.45 k |
Hospitals | 102 | 89 | 83 |
Licensed Beds | 16.24 k | 14.11 k | 13.29 k |
Licensed Healthcare Practitioners | 1 k | 800 | 900 |
Occupancy Rate (Beds in Service) | 45.1% | 44.6% | 51.1% |
Patient Days | 2.47 m | 2.19 m | 2.19 m |
Physicians | 2 k | 1.5 k | 1.5 k |
Psychiatric Hospitals | 2 | 2 | |
States | 18 | 16 | 16 |